# RefleXion Medical: Medical devices, Hayward, United States

> RefleXion Medical: RefleXion Medical is a biotargeting oncology company based in Hayward, California, founded in 2009 by Sam Mazin, Ph.D., and Akshay Nanduri.

Source: https://millionrounds.com/startup/reflexion-medical (Millionrounds; every figure on the page links to its filing or article)

United States · [Medical devices startup](https://millionrounds.com/companies)

# RefleXion Medical

RefleXion Medical is a biotargeting oncology company based in Hayward, California, founded in 2009 by Sam Mazin, Ph.D., and Akshay Nanduri.

Email

Funding reported Last round: Undisclosed round

Medical devices Hayward, United States

Follow RefleXion Medical and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Freflexion-medical)

Company summary

- **Founded:** 2009 17 years old
- **Team:** 260 201 to 1,000 people
- **Funding reported:** $675M in dollars
- **Last round:** Undisclosed round Nov 2023

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for RefleXion Medical has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About RefleXion Medical

RefleXion Medical is a biotargeting oncology company based in Hayward, California, founded in 2009 by Sam Mazin, Ph.D., and Akshay Nanduri.

The company focuses on revolutionizing cancer treatment through its innovative biology-guided radiotherapy (BgRT) system, which utilizes the biology of tumors to direct radiation precisely. This approach allows for effective treatment of both primary and metastatic tumors while minimizing damage to healthy tissue. The flagship product line includes the RefleXion X system, which features the first-generation RefleXion X1 platform, cleared by the FDA in February 2023, and the next-generation RefleXion X2, set for FDA clearance in January 2026. The system employs Positron Emission Tomography (PET) imaging to turn cancer cells into real-time biological beacons, guiding external-beam radiotherapy. RefleXion serves oncology centers, hospitals, and cancer clinics, primarily in the United States, and collaborates with major cancer centers and pharmaceutical companies to enhance cancer care.

## What company datasets say RefleXion Medical raised

Funding, as reported

Reported in all **$675M** in dollars

Rounds **11**

Last round **Undisclosed round**

Last round size **$105M**

Last round date **Nov 2023**

Investors listed **19**

SEC Form D **$413M sold, 6 filings, last Nov 2023**

## Founders and team

From RefleXion Medical's own website and the SEC filings it signed: 19 on the team.

- **Todd Powell** President and Chief Executive Officer
- **Jay Janardhanan** Vice President of Software Engineering
- **Judy J. Bartlett-Roberto** Senior Vice President of Marketing
- **Leonard J. Lyons** Vice President of Sales
- **Gopi Kuduvalli** Chief Research and Development Officer
- **Steven Schoch** Chief Financial Officer
- **Alice T. Schroeder** Independent Director
- **David T. Larkin** Executive Officer i
- **Diana J. King** Executive Officer i
- **Gopinath J. Kuduvalli** Executive Officer i
- **Jeffrey T. Holifield** Executive Officer i
- **Kathy J. O'Shaughnessy** Executive Officer i
- **Leena J. Kadakia** Executive Officer i
- **Martyn T. Webster** Executive Officer i
- **Philip J. Aulson** Executive Officer i
- **Renee T. Ryan** Independent Director
- **Samuel Mazin** Executive Officer, Director i
- **Sean T. Shirvani** Executive Officer i

And 1 more on the team.

On the board, as filed i *Cem T. Usakli* *Fred Moll* *Greg Garfield* *Jay Watkins* *Kevin T. Reilly* *Matthew T. Hobart* *Rana T. Al-Hallaq*

Advisers *Art T. Heidrich*

## The company, in detail

What they build

Known for

theranostic radiotherapy systemic radiotherapy patient care innovation treatment efficacy health care biological targeting multi-tumor treatment next-generation radiotherapy treatment planning real-time imaging medical physics hardware + software cancer in motion manufacturing tumor management systemic radiotherapy for all stages

Built with from their website

Google Maps accessiBe Wistia Google Tag Manager Cisco Switches WordPress.org Atlassian PWA Google Cloud Font Awesome

+8 more

C++ MailChimp CloudFlare Viewport Meta MongoDB Hubspot VMware vCenter Apple Business Manager

- **Sector:** Medical devices
- **Industry code:** NAICS 339112, SIC 3829, 3841
- **Region:** California
- **Revenue:** $109M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/reflexion-medical)

## Medical devices in United States

Startups like it

- [**Precision Neuroscience** New York · founded 2021 *Raised*](https://millionrounds.com/company/precision-neuroscience)
- [**Synchron** New York · founded 2016 *Raised*](https://millionrounds.com/company/synchron)
- [**SetPoint Medical** Santa Clarita · founded 2007 *Raised*](https://millionrounds.com/company/setpoint-medical)
- [**Apreo Health** Menlo Park *Raised*](https://millionrounds.com/company/apreo-health)
- [**Cleerly** Denver · founded 2017 *Raised*](https://millionrounds.com/company/cleerly)
- [**CereVasc** Boston · founded 2013 *Raised*](https://millionrounds.com/company/cerevasc)
- [**Galvanize** Redwood City · founded 2015 *Raised*](https://millionrounds.com/company/galvanize)
- [**Endovascular Engineering, Inc. (E2)** Startup *Raised*](https://millionrounds.com/company/endovascular-engineering-inc-e2)

## Is this your company?

Add your raise, your deck and your story, and put RefleXion Medical in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)